Suicidality in epileptics on levetiracetam therapy with preceding comorbidity

---

Case Report

Author Details : Ramesh Kannan

Volume : 3, Issue : 2, Year : 2017

Article Page : 77-78

Suggest article by email

Get Permission

---

Abstract

Anti-epileptic medications like levetiracetam, sodium valproate, topiramate and lamotrigine are known to produce serious adverse reactions like suicidal tendencies, Steven Johnson syndrome, toxic epidermal necrolysis, hepatic dysfunction, pacreatitis, depression and psychotic episodes. Here we report two patients who attempted suicide, had psychiatric comorbidity and alcoholism and were on treatment. One patient died and the other was treated for poisoning and survived.
Both the patients were on levetiracetam. It is assumed that levetiracetam could have contributed to the suicidal ideation as an adverse reaction. SUDEP (sudden unexplained death in epilepsy) might as well be considered in the second patient. It is suggested that patients on newer anti epileptics be screened for suicidal intent and treated for psychiatric comorbidity like depression. One of the patients had alcoholism and the other comorbid depression.

Keywords: Levetiracetam, Suicide, Epilepsy, Alcohol dependence, Sudep.

How to cite : Kannan R, Suicidality in epileptics on levetiracetam therapy with preceding comorbidity. J Prev Med Holist Health 2017;3(2):77-78

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.